BTMD vs. EXEL
BTMD (biote Corp) and EXEL (Exelixis, Inc.) are both stocks. Both are in the Healthcare sector — BTMD in Medical Care Facilities, EXEL in Biotechnology. Over the past 5 years, BTMD returned -26.08%/yr vs 17.56%/yr for EXEL. At a 0.07 correlation, their price movements are largely independent.
Performance
BTMD vs. EXEL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BTMD achieves a -17.31% return, which is significantly lower than EXEL's 17.13% return.
BTMD
- 1D
- -4.44%
- 1M
- 8.04%
- YTD
- -17.31%
- 6M
- -18.25%
- 1Y
- -46.38%
- 3Y*
- -31.05%
- 5Y*
- -26.08%
- 10Y*
- —
EXEL
- 1D
- -0.02%
- 1M
- 2.37%
- YTD
- 17.13%
- 6M
- 10.15%
- 1Y
- 18.38%
- 3Y*
- 37.24%
- 5Y*
- 17.56%
- 10Y*
- 20.91%
BTMD vs. EXEL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
BTMD biote Corp | -17.31% | -57.93% | 25.10% | 32.44% | -61.94% | -2.49% |
EXEL Exelixis, Inc. | 17.13% | 31.62% | 38.81% | 49.56% | -12.25% | -25.78% |
Correlation
The correlation between BTMD and EXEL is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.15 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.12 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.06 |
Correlation (All Time) Calculated using the full available price history since Apr 28, 2021 | 0.07 |
Fundamentals
BTMD:
$77.39M
EXEL:
$13.72B
BTMD:
$0.44
EXEL:
$3.00
BTMD:
4.84
EXEL:
17.13
BTMD:
0.03
EXEL:
0.30
BTMD:
0.40
EXEL:
6.01
BTMD:
$188.16M
EXEL:
$2.38B
BTMD:
$131.93M
EXEL:
$1.70B
BTMD:
$21.17M
EXEL:
$991.79M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BTMD vs. EXEL — Risk / Return Rank
BTMD
EXEL
BTMD vs. EXEL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for biote Corp (BTMD) and Exelixis, Inc. (EXEL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BTMD | EXEL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.18 | ||
| Sortino ratioReturn per unit of downside risk | -1.70 | ||
| Omega ratioGain probability vs. loss probability | 0.90 | 1.13 | -0.23 |
| Calmar ratioReturn relative to maximum drawdown | -0.65 | 0.73 | -1.38 |
| Martin ratioReturn relative to average drawdown | -1.04 | 1.77 | -2.81 |
Loading charts...
Drawdowns
BTMD vs. EXEL - Drawdown Comparison
The maximum BTMD drawdown since its inception was -87.13%, smaller than the maximum EXEL drawdown of -97.38%. Use the drawdown chart below to compare losses from any high point for BTMD and EXEL.
Loading charts...
Drawdown Indicators
| BTMD | EXEL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -87.13% | -97.38% | +10.25% |
Max Drawdown (1Y)Largest decline over 1 year | -71.43% | -25.16% | -46.27% |
Max Drawdown (3Y)Largest decline over 3 years | -84.45% | -25.34% | -59.11% |
Max Drawdown (5Y)Largest decline over 5 years | -87.08% | -36.12% | -50.96% |
Max Drawdown (10Y)Largest decline over 10 years | — | -57.20% | — |
Current DrawdownCurrent decline from peak | -78.71% | -4.04% | -74.67% |
Average DrawdownAverage peak-to-trough decline | -44.06% | -70.96% | +26.90% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 44.69% | 10.42% | +34.27% |
Volatility
BTMD vs. EXEL - Volatility Comparison
biote Corp (BTMD) has a higher volatility of 21.07% compared to Exelixis, Inc. (EXEL) at 9.38%. This indicates that BTMD's price experiences larger fluctuations and is considered to be riskier than EXEL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BTMD | EXEL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 21.07% | 9.38% | +11.69% |
Volatility (6M)Calculated over the trailing 6-month period | 47.53% | 25.53% | +22.00% |
Volatility (1Y)Calculated over the trailing 1-year period | 64.79% | 40.28% | +24.51% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 67.38% | 37.17% | +30.21% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 66.36% | 44.48% | +21.88% |
Dividends
BTMD vs. EXEL - Dividend Comparison
Neither BTMD nor EXEL has paid dividends to shareholders.
Financials
BTMD vs. EXEL - Financials Comparison
This section allows you to compare key financial metrics between biote Corp and Exelixis, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BTMD vs. EXEL - Profitability Comparison
BTMD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, biote Corp reported a gross profit of 30.95M and revenue of 44.94M. Therefore, the gross margin over that period was 68.9%.
EXEL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Exelixis, Inc. reported a gross profit of 0.00 and revenue of 610.81M. Therefore, the gross margin over that period was 0.0%.
BTMD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, biote Corp reported an operating income of 3.17M and revenue of 44.94M, resulting in an operating margin of 7.1%.
EXEL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Exelixis, Inc. reported an operating income of 251.34M and revenue of 610.81M, resulting in an operating margin of 41.2%.
BTMD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, biote Corp reported a net income of 2.28M and revenue of 44.94M, resulting in a net margin of 5.1%.
EXEL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Exelixis, Inc. reported a net income of 210.47M and revenue of 610.81M, resulting in a net margin of 34.5%.
Frequently Asked Questions
BTMD and EXEL have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BTMD has higher volatility (21.07%) compared to EXEL (9.38%). In terms of maximum drawdown, BTMD dropped -87.13% vs EXEL's -97.38%.
EXEL currently has the higher Sharpe Ratio (0.47 vs -0.72), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BTMD and EXEL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer